Workshop Workshop A track
Build, Buy, or Partner? Choosing Your Market Entry Strategy
Mon, Nov 9, 2026 · 9:00–10:00 AM CET Regulatory Strategy Stage, Koelnmesse
About this session
Interactive Workshop For a company at early or later-stage development considering commercialisation, few decisions carry more lasting impact than how to enter the market: partnering or licensing with an established regional player, building a commercial organization and launching independently, or some combination of the two. Each path changes the value the company ultimately captures, the capital it must commit, the risk it absorbs, and the organization it becomes. This panel brings together senior biopharma leaders who chose differing strategic pathways across regions.
